T1	Participants 74 119	patients with locally advanced gastric cancer
T2	Participants 711 796	156 patients with stage III or IV gastric cancer who had undergone curative resection
T3	Participants 1252 1287	patients with pT2/T3 primary tumors
T4	Participants 1454 1511	patients with intestinal-type but not diffuse-type cancer
T5	Participants 1767 1829	patients with pT2/T3 tumors and intestinal-type primary tumors
T6	Participants 1697 1747	gastric cancer patients after curative gastrectomy
